Novant Health

Charlotte, North Carolina 28413

5 studies enrolling now · 21 studies all time

What they study most

AML, Adult, AV Block, Acute Lymphoblastic Leukemia, Adult B-Cell, Acute Myeloid Leukemia, Brain Hemorrhage, CD20 Positive Non Hodgkin Lymphoma, CLL/SLL, Carcinoma, Cardiovascular Disease, Cerebral Hemorrhage, Cerebral Parenchymal Hemorrhage, Chronic Lymphocytic Leukemia

Studies at this site

• A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma — Recruiting now
• Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II — Recruiting now
• Left vs Left Randomized Clinical Trial — Recruiting now
• Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study — Completed
• A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies — Running, not enrolling
• A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Running, not enrolling
• Dose Escalation and Expansion Study of CPO107 for Patients With Advanced CD20-positive Non-Hodgkins Lymphoma — Stopped early
• Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma — Available (expanded access)
• MIND: Artemis in the Removal of Intracerebral Hemorrhage — Completed
• Addressing Cancer-Related Financial Toxicity in Rural Oncology Care Settings — Completed
• A Study of Duvelisib in Participants With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) — Completed
• Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) — Stopped early
• LCI-HEM-SCD-ST3P-UP-001: The Sickle Cell Trevor Thompson Transition Project (ST3P-UP Study) — Completed
• The clonoSEQ® Watch Registry — Stopped early
• Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence — Completed
• A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML) — Status unconfirmed
• Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19 — Completed
• The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee — Completed
• Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer — Completed